IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals

Reuters

07-30

IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals

IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2555804320"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555804320\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2555804320?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-30 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555804320","market":"nz","top_or_hot":-1,"title":"IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-30 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDLC0gzc:1","article_id":"2555804320","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555804320","pubTimestamp":1753873365,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx Cellular Analyzer and IDEXX Cancer Dx testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4567":"ESG概念","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","BK4504":"桥水持仓","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","BK4585":"ETF&股票定投概念","BK4588":"碎股","IDXX":"爱德士实验室","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC"},"translate_title":"IDEXX Laboratories发布2024年企业责任报告，详细介绍ESG目标进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDXX":0.9},"content_text":"IDEXX Laboratories Releases 2024 Corporate Responsibility Report, Detailing Progress on ESG Goals\n    \n\n        IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC39137) on July 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}